Format

Send to

Choose Destination
Sci Rep. 2017 Feb 21;7:42891. doi: 10.1038/srep42891.

Anti-inflammatory and anti-excitoxic effects of diethyl oxopropanamide, an ethyl pyruvate bioisoster, exert robust neuroprotective effects in the postischemic brain.

Lee HK1,2, Kim ID1,2, Kim SW1,3, Lee H1,2, Park JY4, Yoon SH4, Lee JK1,2.

Author information

1
Department of Anatomy, Inha University School of Medicine, Inchon, Republic of Korea.
2
Medical Research Center, Inha University School of Medicine, Inchon, Republic of Korea.
3
Department of Biomedical Sciences, Inha University School of Medicine, Inchon, Republic of Korea.
4
Department of Molecular Science and Technology, Ajou University, Suwon, Republic of Korea.

Abstract

Ethyl pyruvate (EP) is a simple aliphatic ester of pyruvic acid and has been shown to have robust neuroprotective effects via its anti-inflammatory, anti-oxidative, and anti-apoptotic functions. In an effort to develop novel EP derivatives with greater protective potencies than EP, we generated four EP isosteres, among them the neuroprotective potency of N,N-diethyl-2-oxopropanamide (DEOPA), in which the ethoxy group of EP was replaced with diethylamine, was far greater than that of EP. When DEOPA was administered intravenously (5 mg/kg) to rat middle cerebral artery occlusion (MCAO) model at 6 hrs post-surgery, it suppressed infarct formation, ameliorated neurological and sensory/motor deficits, and inhibited microglial activation and neutrophil infiltrations in the postischemic brain more effectively than EP. In particular, DEOPA markedly suppressed LPS-induced nitrite production and cytokine/chemokine inductions in microglia, neutrophils, and endothelial cells and these effects are attributable to inhibition of the activity of NF-κB by suppressing IκB-α degradation and p65 to DNA binding. In addition, DEOPA suppressed NMDA-induced neuronal cell death in primary cortical neuron cultures by NAD replenishment and suppression of NF-κB activity. Together, these results indicate DEOPA has multi-modal protective effects against ischemic brain damage targeting numerous cell types in the brain and also against other inflammation-related diseases.

PMID:
28220827
PMCID:
PMC5318887
DOI:
10.1038/srep42891
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center